Home
0086-571-8627 3270
service@chemball.com
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >
Entecavir
CAS NO.: 142217-69-4
FOB Price: NEGOTIABLE Get Latest Price
Specification: USP/EP
Documentation: Get COA after inquiry
Lead Time: 14-30 days
Max Capacity: -
Packing: 25KG/Fibre Drum
Product Detail
Properties

Entecavir


Synonymous:

(1S,3R,4S)-9-[4-Hydroxy-3-(Hydroxymethyl)-2-Methylenecyclopentyl]Guanine

CAS:

142217-69-4

Molecular Formula:

C12H15N5O3

Molecular Weight:

277.279

Appearance

white to beige powder

Storage

-20°C

Category

Treatment of hepatitis B virus infection drugs



Product introduction:

Entecavir is a new generation of guanine nucleoside analogues used in the treatment of hepatitis B virus infection. It is mainly used to treat adult chronic hepatitis B with active viral replication and continuous elevated serum aminotransferase, or liver histologically active disease. It is the fastest and strongest nucleoside analogues with the lowest mutation rate. The data indicate that different chronic hepatitis B patients, including nucleoside and cirrhosis, can control the disease quickly and safely through the entecavir tablet, and arrive at the real end point of treatment easily, that is, hepatitis B virus is undetectable. By adhering to the treatment, a considerable number of patients can reach the satisfactory end point of treatment, that is, seroconversion of e antigen, and some patients can even reach the ideal end point of treatment, that is, negative conversion of surface antigen.


Indication:

This product is suitable for active virus replication, It is also suitable for the treatment of chronic adult hepatitis B with persistent elevation of serum alanine aminotransferase (ALT) or liver histology showing active lesions. It is also suitable for the treatment of nucleoside untreated children with chronic HBV infection compensated liver disease aged 2 to < 18 years. There is evidence of active virus replication and persistent elevation of serum ALT level or histological evidence of moderate to severe inflammation and / or fibrosis.


Taboos:

It is prohibited for those allergic to entecavir or any ingredient in the preparation.


Matters needing attention:

Patients should take entecavir under the guidance of doctors, and inform doctors of any new symptoms and drug combinations. The patient should be informed that if the drug is stopped, sometimes the liver condition will worsen, so the treatment method should be changed under the guidance of the doctor. Entecavir treatment did not reduce the risk of HBV transmission through sexual contact or contaminated blood sources. Therefore, appropriate protective measures need to be taken.





Send your message to this supplier
To:
JIANGSU WISDOM PHARMACEUTICAL CO.,LTD
From:
Please enter your email
Message:
You did not fill in the message!
You can upload 6 files at most
Add Attachment
SEND SUCCESSFUL!
SEND FAILED
Not exactly what you want? One request, multiple quotations Get Quotations Now >>
24YRS
Business Type:
Manufacturing
Country/Region:
Jiangsu, China
Contacts:
Manager Sha
Position Title:
Sales Manager
Tel:
0086-513- 81292228
Visit Factory
Get Free Samples
Less than 1KG required
Please enter the correct email address
Please enter quantity
Please enter remark